
    
      This will be a 4-week multicentre, randomized, open label, parallel group, active control
      study to evaluate efficacy and safety of Targin in comparison with Oxycontin in Korean
      patients with cancer pain who are administered weak opioid or na√Øve patients including
      patient not on the long term strong opioid medication within 3 months.
    
  